CD4 and melanoma: These findings are roughly consistent with the microarray phenotype of TRP-1 transgenic cytotoxic CD4+ T cells obtained from lymphopenic mice with regressing melanoma tumors (Xie et al., 2010), although comparisons are limited between this prior bulk microarray data and single-cell transcriptomic data.